The possibility of treatment with dienogest 2 mg in patients with genital endometriosis
OA: bronze
CC0
⤵ 14 in-corpus citations
AI-generated summary
This paper investigated the efficacy of dienogest 2 mg for treating genital endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (42)
- A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis via openalex
- Advances in the management of endometriosis: an update for clinicians via openalex
- Angiogenesis, lymphangiogenesis and neurogenesis in endometriosis via openalex
- Changes in quality of life after hormonal treatment of endometriosis via openalex
- Depressive symptoms, anxiety, and quality of life in women with pelvic endometriosis via openalex
- Dienogest: an oral progestogen for the treatment of endometriosis via openalex
- Dienogest: a review of its use in the treatment of endometriosis via openalex
- Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Dienogest mediates midkine suppression in endometriosis via openalex
- Dienogest reduces HSD17β1 expression and activity in endometriosis via openalex
- Economic burden of endometriosis via openalex
- Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats via openalex
- Endometriosis and self-management strategies via openalex
- Endometriosis: cost estimates and methodological perspective via openalex
- Endometriosis in adolescence via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Examination: Endometriosis—A Missed Malady via openalex
- Faculty Opinions recommendation of The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. via openalex
- Health-Related Quality of Life Burden for Women With Endometriosis via openalex
- High levels of anxiety and depression have a negative effect on quality of life of women with chronic pelvic pain via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Importance of genital endometriosis in pathogenesis of infertility via openalex
- Inflammation and nerve fiber interaction in endometriotic pain via openalex
- Laparoscopic treatment of complete obliteration of the cul-de-sac associated with endometriosis: long-term follow-up of en bloc resection via openalex
- Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? via openalex
- Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis via openalex
- Patients' report on how endometriosis affects health, work, and daily life via openalex
- Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells via openalex
- Quality of sex life in women with endometriosis and deep dyspareunia via openalex
- Social isolation in women with endometriosis and chronic pelvic pain via openalex
- The comparison of the efficacy of different regimens of postoperative hormonal therapy in infertile women with endometriosis via openalex
- The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis via openalex
- The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey via openalex
- The use of newer progestins for contraception via openalex
- W2085922363 via openalex
- doi:10.1016/j.fertnstert.2006.07.714 via openalex
- W2123134517 via openalex
- W2021687464 via openalex
- W2005355775 via openalex
- W2101417341 via openalex
Cited by (14)
- Efficacy and safety endpoints of dienogest treatment of endometriosis: a systematic review 2025
- Modern strategies in the treatment of endometriosis 2025
- Efficiency of using dienogest at the stage of pregravid preparation on the course of pregnancy and the outcome of childbirth in patients with endometriosis 2024
- TACTICS FOR MANAGING PATIENTS WITH ENDOMETRIOID CYSTS AND INFERTILITY. CLINICAL CASE 2024
- [Psychoemotional state and sexual function in women with chronic pelvic pain in genital endometriosis] 2024
- Endometriosis-associated pain and new therapeutic options: A review 2023
- Evaluation of bovhyaluronidase azoxymer efficacy in combined treatment of patients with endometriosis based on the results of multicenter prospective non-interventional study (ISLAND) 2021
- Study of dienogest clinical efficacy in the treatment of adenomyosis 2021
- Chronic pelvic pain in patients of reproductive age with endometriosis 2021
- DIENOGEST IN POST OPERATIVE MANAGEMENT’S OF PATIENT’S WITH ENDOMETRIOSIS 2020
- Postoperative management of patients with endometriosis 2020
- Deep infiltrative endometriosis. Contentious issues: pros and cons 2020
- Hormone therapy for patients with endometriosis: status update on the problem (literature review) 2020
- Endometrioma: a new paradigm of diagnostics and therapeutic tactics 2019
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK